All Resources

Read all of the latest breakthroughs, insights, and news from Ginkgo.

BlogSeptember 24, 2024
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
BlogApril 10, 2024
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks
BlogMarch 18, 2024
Welcome Dr. Mitch Wolfe!
BlogFebruary 27, 2024
Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center, CUBE-D, Establishing Middle East Hub for Global Bioradar, at Qatar Free Zones
BlogFebruary 13, 2024
House Select Committee Tours Ginkgo Bioworks, Previews Biofab1, Ginkgo’s New Integrated Data Generation Facility Set to Launch in 2025
BlogSeptember 21, 2021
The End of the Beginning: Ginkgo Goes Public
BlogJune 9, 2021
600,000 Noses Swabbed!
BlogMay 14, 2021
Taking Ginkgo Public on NYSE:DNA
BlogMarch 18, 2021
Why Ginkgo Cares about Genetic Privacy
BlogDecember 8, 2020
Expanding Ginkgo's Platform for Biosecurity and Pandemic Responsiveness
BlogNovember 16, 2020
Webinar: University Leaders on Testing
BlogOctober 23, 2020
Our New Seaport Test Center: Expanding Access to COVID-19 Diagnostic Testing in Boston
BlogJune 30, 2020
Needle in a Haystack: Looking for Compounds to Treat COVID-19
BlogJune 18, 2020
Concentric by Ginkgo: COVID-19 testing at scale
BlogMay 4, 2020
How to Deploy Millions of COVID-19 Tests Per Day
BlogApril 17, 2020
Teaming Up to Improve Antibody Therapeutics for COVID-19
BlogApril 15, 2020
Supporting COVID-19 mRNA Vaccine Development with Moderna
BlogApril 10, 2020
Project Update: COVID-19 DNA Synthesis
BlogMarch 24, 2020
Scaling Up Whole Genome Sequencing of COVID-19
BlogMarch 22, 2020
Synthetic Biology (and beyond) Community response to COVID-19
BlogMarch 20, 2020
Fighting COVID-19 by Synthesizing DNA
BlogMarch 17, 2020
$25M of Free Platform Access for COVID-19 Projects
BlogJune 26, 2018
Our Work on Biosecurity with IARPA